Carmed Pharmaceuticals, a research-driven company specializing in standardized carvacrol-based formulations, announced that four of its flagship wellness formulations are expected to become available soon through Walmart.com, expanding consumer access as the company continues its U.S. growth strategy.

The upcoming Walmart.com launch follows Carmed's recent introduction on OneLavi.com and reflects the company's continued focus on making its research-driven wellness formulations available to the U.S.marketplace through leading online retail channels.

As consumer interest in science-informed wellness continues to grow, Carmed says its product development philosophy has remained consistent from the beginning: combining traditional botanical knowledge with modern pharmaceutical methodology to develop plant-based wellness formulations through analytical validation, quality control, and reproducible formulation design.

"Our objective has always been to approach botanical formulation development with scientific discipline," said Mustafa Can, Founder of Carmed Pharmaceuticals. "We focus on standardization, reproducibility, and analytical validation so our formulations are developed through a consistent and research-driven process."

Research Supporting Product Development

Officially established in 2019 following years of focused research and development, Carmed combines botanical science with modern pharmaceutical technology to develop formulations designed to support preventive wellness, immune resilience, microbial balance, respiratory wellness, and cellular health.

The company's development philosophy is supported through ongoing collaboration with researchers, laboratories, healthcare institutions, and scientific advisors.

In 2026, research involving Carmed formulations was published in two peer-reviewed scientific journals. A study published in Plants in January examined Vacrol® and S-Mix® in preclinical laboratory and in ovo models, contributing to the broader scientific investigation of carvacrol-based formulations and multicomponent botanical interactions. A second study, published in Antioxidants in May, further evaluated Vacrol® and S-Mix® in laboratory and preclinical experimental models, examining formulation characteristics, biological activity, and antimicrobial properties. The researchers concluded that the formulations demonstrated distinct biological profiles and warranted further mechanistic and translational investigation.

Carmed emphasizes that these publications represent scientific investigation into formulation science and botanical bioactivity and are not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

"We believe scientific publication is an important part of transparency and long-term credibility," said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. "Publishing in peer-reviewed journals reflects our commitment to advancing scientific understanding while continuing to refine our formulations through ongoing research and collaboration."

Coming Soon to Walmart.com

Carmed Pharmaceuticals expects the following formulations to become available soon on Walmart.com:

• Vacrol® Kids Spray - A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4-11.
• S-Mix® - A synergy-driven formulation designed to support immune function and healthy cellular activity.
• Vacrol® Capsule - A standardized carvacrol formulation developed to support microbial balance and immune resilience.
• Vacrol-M® Capsule - A multi-component botanical formulation designed to support immune function and respiratory wellness.

Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.

The Walmart.com launch follows the recent availability of Carmed formulations on OneLavi.com as part of the company's broader U.S. expansion strategy focused on scientific credibility, educational outreach, and expanding consumer access to its research-driven botanical wellness formulations.

U.S. consumers can purchase Vacrol® Kids Spray, S-Mix® ,Vacrol® Capsule and Vacrol-M® Capsule on OneLavi.com today.

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

For more information, visit Carmed Pharmaceuticals online and follow the company on Instagram.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Summer often brings changes to daily routines as families take vacations, professionals travel for business, and many people spend more time away from home. According to Carmed Pharmaceuticals, maintaining consistent wellness habits during these periods of disruption can help support long-term wellness and lifestyle goals.

The Turkey-based company, which specializes in standardized carvacrol-based formulations and is expanding throughout the United States, says that consistency is often overlooked when people think about wellness.

"Many people work hard to establish healthy routines throughout the year, but travel can quickly disrupt those habits," said Mustafa Can, Founder of Carmed Pharmaceuticals. "The key is not perfection. It is maintaining consistency through simple, sustainable practices that can travel with you."

Five Ways to Stay Consistent While Traveling

Plan Ahead

Preparing for travel before departure can make it easier to maintain healthy routines. Whether traveling for a weekend or an extended vacation, a little planning can help reduce disruptions.

Focus on Daily Habits

Small actions performed consistently often have a greater long-term impact than occasional bursts of effort. Travelers can benefit from maintaining simple wellness practices that fit easily into changing schedules.

Prioritize Rest and Recovery

Travel often involves early mornings, late nights, time zone changes, and packed itineraries. Making time for adequate rest can help support overall wellness and daily performance.

Stay Active Throughout the Day

Long flights, road trips, and conference schedules can lead to extended periods of inactivity. Incorporating movement throughout the day can help travelers maintain healthy routines while away from home.

Choose Consistency and Quality

Consumers are increasingly looking for wellness products developed with quality control, standardization, and transparency in mind. Carmed believes consistency in formulation is an important factor when selecting products intended to support long-term wellness goals.

A Research-Driven Approach to Wellness

Carmed Pharmaceuticals combines traditional botanical knowledge with modern pharmaceutical methodology to develop standardized formulations designed around reproducibility, quality control, and scientific evaluation.

The company's approach is supported by ongoing collaboration with researchers, laboratories, healthcare institutions, and scientific advisors. Carmed formulations have also been evaluated in multiple peer-reviewed scientific publications examining botanical bioactives and formulation science.

"We believe wellness should be viewed as a long-term commitment rather than a seasonal trend," said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. "Summer travel is a great reminder that maintaining simple, consistent habits can often be more valuable than pursuing short-term solutions."

Available Now on OneLavi.com

Carmed states that consistency applies not only to daily habits, but also to the quality and standardization of the wellness products consumers choose. 

U.S. consumers can now purchase the following Carmed Pharmaceuticals formulations on OneLavi.com:

• Vacrol® Kids Spray - A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4-11.

• S-Mix® - A synergy-driven formulation designed to support immune function and healthy cellular activity.

• Vacrol® Capsule - A standardized carvacrol formulation developed to support microbial balance and immune resilience.

• Vacrol-M® Capsule - A multi-component botanical formulation designed to support immune function and respiratory wellness.

Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.

According to Carmed, all formulations are developed using standardized processes designed to support reproducibility, consistency, and quality control.

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

For more information, visit Carmed Pharmaceuticals online and follow the company on Instagram.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Carmed Pharmaceuticals, a research-driven company specializing in standardized carvacrol-based formulations, is highlighting the publication of a new peer-reviewed scientific study involving two of its flagship formulations, Vacrol® and S-Mix®.

The research, recently published in the journal Antioxidants, represents the second peer-reviewed publication in 2026 involving Carmed formulations, further reflecting the company's long-term commitment to scientific investigation, formulation development, and academic collaboration.

The study evaluated Vacrol® and S-Mix® in a series of laboratory and preclinical experimental models, examining formulation characteristics, biological activity, and antimicrobial properties. Researchers concluded that the formulations demonstrated distinct biological profiles and warranted further mechanistic and translational investigation.

Building a Research-Driven Foundation

Unlike many wellness companies that focus primarily on product marketing, Carmed Pharmaceuticals has invested heavily in scientific collaboration and research surrounding its proprietary formulations.

The newly published paper follows a January 2026 peer-reviewed study published in Plants that also evaluated Carmed formulations in experimental models. Together, the publications contribute to a growing body of scientific literature examining standardized carvacrol-based formulations and their biological properties.

"Scientific inquiry has always been central to our philosophy," said Mustafa Can, Founder of Carmed Pharmaceuticals. "We believe meaningful innovation requires ongoing research, independent evaluation, and a willingness to explore important scientific questions through rigorous study."

The company emphasizes that the published research reflects scientific investigation into formulation science and biological mechanisms and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

Supporting Long-Term Scientific Exploration

Carmed's development approach focuses on standardized botanical formulations designed around reproducibility, analytical validation, and quality control.

The company collaborates with researchers, laboratories, healthcare institutions, and scientific advisors as part of its broader research ecosystem. These collaborations support ongoing investigation into botanical bioactives, formulation design, and potential mechanisms of action.

"Research is not a marketing exercise for us," said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. "We view scientific publication as an important part of transparency and long-term credibility. Our goal is to continue contributing to the scientific conversation while making our formulations more accessible to consumers."

Expanding Availability in the United States

The publication comes as Carmed continues its expansion into the United States market.

Several Carmed formulations, coming soon to Amazon, are now available to U.S. consumers through OneLavi.com, including:

•  Vacrol® Kids Spray - A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4-11.

• S-Mix® - A synergy-driven formulation designed to support immune function and healthy cellular activity.

• Vacrol® Capsule - A standardized carvacrol formulation developed to support microbial balance and immune resilience.

• Vacrol-M® Capsule - A multi-component botanical formulation designed to support immune function and respiratory wellness.

According to the company, expanding retail availability alongside continued scientific publication reflects Carmed's broader strategy of combining research, quality-focused formulation development, and long-term brand building as it establishes its presence in the U.S. market.

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

Visit Carmed Pharmaceuticals website and visit them on Instagram.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Carmed Pharmaceuticals, a Turkey-based, science-driven company specializing in standardized carvacrol-based formulations, has earned editorial coverage in CityBiz through a featured executive Q&A with Founder Mustafa Can as the company continues expanding into the United States market.

The CityBiz interview explores Can’s unconventional journey from ship master in the maritime industry to founder of a research-focused pharmaceutical company built around standardized botanical formulations and long-term scientific development. The feature also discusses Carmed’s formulation philosophy, ongoing research initiatives, and strategy for entering the U.S. wellness market.

Founder Story and Research-Driven Philosophy

In the interview, Can explains how a personal interest in longevity and preventive wellness led him into years of independent research studying botanical compounds and formulation science before formally establishing Carmed Pharmaceuticals.

“Over time, this personal journey evolved into something more structured,” Can said in the CityBiz feature. “I became increasingly focused on how to develop standardized, reproducible formulations based on bioactive compounds like carvacrol.”

The article also highlights Carmed’s emphasis on what the company describes as “rational synergy” - combining multiple bioactive compounds within standardized formulations designed around consistency, reproducibility, and analytical validation.

Building Awareness Ahead of Broader U.S. Distribution

The CityBiz placement comes as Carmed continues building awareness in the United States through a multi-channel distribution strategy that includes both curated wellness platforms and large-scale digital marketplaces.

Several Carmed formulations are now available on OneLavi.com, including:

• Vacrol® Kids Spray - A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4-11.

• S-Mix® - A synergy-driven formulation designed to support immune function and healthy cellular activity.

• Vacrol® Capsule - A standardized carvacrol formulation developed to support microbial balance and immune resilience.

• Vacrol-M® Capsule - A multi-component botanical formulation designed to support immune function and respiratory wellness.

Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.

The company also previously announced plans to expand availability through Amazon as part of its broader U.S. rollout strategy.

“We believe educational visibility and accessibility must develop together,” said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. “The CityBiz feature helps communicate the philosophy behind Carmed while platforms like OneLavi and Amazon help make our formulations more accessible to consumers in the United States.”

Scientific Collaboration and Ongoing Research

The CityBiz interview also discusses Carmed’s commitment to scientific collaboration and ongoing research. According to the feature, Carmed works alongside physicians, researchers, laboratories, and academic partners to support formulation development and scientific evaluation.

In January 2026, research involving Carmed formulations Vacrol® and S-Mix® was published in the peer-reviewed journal Plants, where the formulations were examined in preclinical laboratory and in ovo models as part of broader scientific investigation into carvacrol-based botanical formulations.

The company emphasizes that this research reflects scientific investigation into formulation science and botanical bioactivity and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

Expanding a Long-Term U.S. Presence

Carmed states that its U.S. strategy is focused on long-term brand development through scientific credibility, regulatory alignment, educational visibility, and expanded consumer accessibility.

“Our goal is to build a company that is known for consistency, credibility, and a long-term commitment to research-driven development,” Can said in the CityBiz feature.

The full CityBiz Q&A with Mustafa Can can be viewed here.

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

Visit Carmed Pharmaceuticals website and visit them on Instagram.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Carmed Pharmaceuticals, a Turkey-based, science-driven company specializing in standardized carvacrol-based formulations, announced that select products are now available on OneLavi.com, a curated online marketplace focused on beauty, health, and wellness brands.

The launch marks another milestone in Carmed’s ongoing expansion into the United States market and follows the company’s previously announced plans to broaden availability through multiple digital retail channels, including Amazon.

Carmed’s approach combines traditional botanical knowledge with modern pharmaceutical methodology to develop standardized formulations designed to support immune resilience, cellular health, and overall physiological balance.

Carmed Formulations Now Available on OneLavi.com

Through OneLavi.com, U.S. consumers can now access several of Carmed Pharmaceuticals’ flagship formulations, including:

• Vacrol® Kids Spray - A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4-11.

• S-Mix® - A synergy-driven formulation designed to support immune function and healthy cellular activity.

• Vacrol® Capsule - A standardized carvacrol formulation developed to support microbial balance and immune resilience.

• Vacrol-M® Capsule - A multi-component botanical formulation designed to support immune function and respiratory wellness.

Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.

According to the company, all formulations are developed using standardized processes designed to ensure consistency, reproducibility, and quality control across production.

Expanding Through Curated Wellness Platforms

Carmed states that OneLavi’s curated marketplace aligns with the company’s long-term strategy of introducing its formulations through platforms that emphasize quality, product transparency, and wellness-focused discovery.

“Launching on OneLavi represents an important step in making our formulations accessible to consumers in the United States,” said Mustafa Can, Founder of Carmed Pharmaceuticals. “We believe curated wellness platforms provide an environment where consumers can better understand the value of standardized, research-driven formulations.”

Scientific Foundation and Ongoing Research

Carmed’s formulation approach is supported by ongoing collaboration with academic institutions, laboratories, and medical researchers focused on bioactive compounds and formulation science.

In January 2026, a study published in the peer-reviewed journal Plants examined Vacrol® and S-Mix® in preclinical laboratory and in ovo models, contributing to broader scientific investigation involving carvacrol-based formulations and multicomponent botanical interactions.

The company emphasizes that this research reflects scientific investigation into botanical bioactivity and formulation science and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

Building Long-Term Presence in the U.S.

Carmed states that its U.S. strategy is focused on long-term brand development through scientific credibility, regulatory alignment, and expanded consumer accessibility.

“We are excited to officially introduce Carmed to OneLavi’s wellness-focused audience,” said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. “This launch supports our broader vision of building a trusted international wellness brand as we continue expanding throughout the United States.”

Consumers can learn more and shop Carmed Pharmaceuticals products at OneLavi.com: Vacrol® Kids Spray,  S-Mix®, Vacrol® Capsule and Vacrol-M® Capsule.

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

Visit Carmed Pharmaceuticals website and visit them on Instagram.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Carmed Pharmaceuticals, a Turkey-based, research-driven company specializing in standardized carvacrol-based formulations, has launched a large-scale social responsibility initiative titled “Farkındayım”, as part of its broader global vision and ongoing expansion into the United States.

The project brings together 32 artists in a collaborative musical production supported by a cinematic visual narrative filmed across 17 animal shelters in nine cities throughout Turkey. Designed to raise awareness and generate direct support for stray animals, the initiative introduces a model in which every video view and music stream contributes to animal welfare efforts without requiring additional action from the audience.

A New Model for Measurable Social Impact

“Farkındayım,” which translates to “I am aware,” reflects Carmed’s effort to integrate social responsibility into scalable, measurable systems.

The initiative is designed to:

• Transform passive viewers into active contributors

• Combine art, technology, and social responsibility into a unified impact model

• Direct proceeds transparently to animal welfare organizations

By linking digital engagement directly to funding, the project creates a mechanism where awareness and action occur simultaneously.

“This project reflects our belief that impact should be both meaningful and measurable,” said Mustafa Can, Founder of Carmed Pharmaceuticals. “We wanted to create a system where people can contribute simply by engaging, while ensuring transparency and real-world benefit.”

Creative Collaboration and National Reach

The campaign’s production spans multiple regions and creative disciplines, featuring contributions from 32 artists and on-location filming across a network of shelters.

A premiere event was held at Fişekhane in Istanbul on April 3, bringing together members of the creative community, media representatives, and project stakeholders ahead of the initiative’s broader release.

The official video and song are available online and form the core of the campaign’s engagement model. The project’s music is also available on Spotify, including “Dikenlerin Üzerinde Yürüyorum (I Walk on Thorns)” and its instrumental version, expanding access across streaming platforms. Since its release in early April, the video has generated more than 10,000 views and over 150 audience comments, reflecting early engagement and public response to the initiative.

A Purpose-Driven Brand Expanding Globally

While Carmed Pharmaceuticals is known for its research-driven approach to botanical formulation development, the company states that social responsibility is an integral part of its long-term vision.

“Farkındayım represents how we think about impact as a company,” said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. “As we expand internationally, including into the United States, we want to demonstrate that scientific development and social responsibility can move forward together.”

Building Awareness Ahead of U.S. Expansion

Carmed’s launch of “Farkındayım” comes as the company continues to expand its presence in the United States, including planned distribution through major digital platforms such as Amazon.

The company’s U.S. strategy focuses on building long-term credibility through research-driven product development, regulatory alignment, and increased brand visibility.

As Carmed enters new markets, initiatives like “Farkındayım” are intended to reflect a broader commitment to innovation, transparency, and global impact beyond product development alone.

Additional information, media assets, and campaign materials are available upon request.

Explore the Project 

Watch the official “Farkındayım” campaign video on YouTube.

Listen to the music on Spotify:

• Dikenlerin Üzerinde Yürüyorum (I Walk on Thorns)

• Dikenlerin Üzerinde Yürüyorum (Instrumental)
  

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

Visit Carmed Pharmaceuticals website and visit them on Instagram.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Carmed Pharmaceuticals, a Turkey-based, science-driven company specializing in standardized carvacrol-based formulations, announced plans to expand its U.S. distribution with an upcoming launch on OneLavi, a curated online marketplace for beauty, health, and wellness products.

The planned launch represents another step in Carmed’s U.S. expansion strategy, focused on increasing accessibility to its research-driven formulations while building long-term credibility in the American market.  The OneLavi launch follows Carmed’s previously announced plans to introduce its formulations on Amazon, reflecting a broader multi-channel approach to U.S. distribution.

Carmed’s approach integrates traditional botanical knowledge with modern pharmaceutical methodology to develop standardized formulations designed to support immune resilience, cellular health, and overall physiological balance.

Expanding Through Curated Digital Retail

The addition of OneLavi to Carmed’s distribution strategy reflects the company’s focus on reaching consumers through curated platforms that emphasize quality, transparency, and product discovery.

Unlike broader marketplaces, OneLavi provides a more selective environment where brands are positioned alongside premium wellness offerings, allowing Carmed to introduce its formulations within a more focused consumer experience.

“Expanding onto OneLavi allows us to introduce our formulations in a curated environment where quality and product integrity are prioritized,” said Mustafa Can, Founder of Carmed Pharmaceuticals. “This aligns with our commitment to standardized development and consistent formulation quality.”

Product Portfolio Coming to OneLavi

As part of its OneLavi launch, Carmed Pharmaceuticals plans to introduce several of its core formulations:

• Vacrol® Kids Spray - A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4-11.

• S-Mix® - A synergy-driven formulation designed to support immune function and healthy cellular activity.

• Vacrol® Capsule - A standardized carvacrol formulation developed to support microbial balance and immune resilience.

• Vacrol-M® Capsule - A multi-component botanical formulation designed to support immune function and respiratory wellness.

• Omevaq-3® - A targeted formulation developed to support cellular energy metabolism and cognitive wellness.

Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.

According to the company, all formulations are developed using standardized processes designed to ensure consistency, reproducibility, and quality control across production.

Research-Driven Development and Scientific Collaboration

Carmed’s formulation approach is supported by ongoing collaboration with academic institutions, laboratories, and medical researchers focused on bioactive compounds and formulation science.

In January 2026, a study published in the peer-reviewed journal Plants examined Vacrol® and S-Mix® in preclinical laboratory and in ovo models, contributing to the broader scientific investigation of carvacrol-based formulations and multicomponent botanical interactions.

The company emphasizes that this research reflects scientific investigation into formulation science and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

Strengthening U.S. Market Presence

Carmed states that its U.S. strategy is centered on expanding availability across both large-scale and curated retail platforms while maintaining alignment with regulatory standards and long-term scientific positioning.

“The OneLavi launch is an important step in building awareness and accessibility for Carmed in the United States,” said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. “We are focused on introducing our formulations to new audiences while maintaining the same standards of quality, consistency, and research-driven development.”

Availability timelines and product listings on OneLavi will be announced in the coming weeks.

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

Visit Carmed Pharmaceuticals website and visit them on Instagram.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Carmed Pharmaceuticals, a science-driven company specializing in standardized carvacrol-based formulations, is preparing to expand its U.S. distribution with an upcoming launch on Amazon.

The planned rollout marks an important step in increasing accessibility to Carmed’s formulations, enabling U.S. consumers to discover and purchase its products through a widely used digital marketplace.

Built on a foundation of structured research and formulation science, Carmed develops standardized botanical formulations designed to support immune resilience, cellular health, and overall physiological balance.

Advancing U.S. Availability Through Digital Channels

Carmed’s expansion onto Amazon reflects the company’s strategy of pairing scientific development with modern distribution platforms that improve product accessibility and consumer reach.

The company aims to meet growing demand for quality-controlled botanical formulations by making its products easier to access through familiar purchasing channels.

“Our focus is to deliver formulations that are consistent, standardized, and grounded in scientific methodology,” said Mustafa Can, Founder of Carmed Pharmaceuticals. “Expanding onto Amazon allows us to reach a broader audience while maintaining the same commitment to research and quality that defines our work.”

Product Portfolio Planned for Amazon

As part of its Amazon rollout, Carmed Pharmaceuticals plans to introduce several of its core formulations:

• Vacrol® Kids Spray - A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4-11.

• S-Mix® - A synergy-driven formulation designed to support immune function and healthy cellular activity.

• Vacrol® Capsule - A standardized carvacrol formulation developed to support microbial balance and immune resilience.

• Vacrol-M® Capsule - A multi-component botanical formulation designed to support immune function and respiratory wellness.

• Omevaq-3® - A targeted formulation developed to support cellular energy metabolism and cognitive wellness.

Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.

According to the company, all formulations are developed using standardized processes designed to ensure consistency, reproducibility, and quality control across production.

Research-Driven Development Model

Carmed’s formulation approach is supported by ongoing collaboration with academic institutions, laboratories, and medical researchers focused on bioactive compounds and formulation science.

In January 2026, a study published in the peer-reviewed journal Plants examined Vacrol® and S-Mix® in preclinical laboratory and in ovo models, contributing to the broader scientific investigation of carvacrol-based formulations and multicomponent botanical interactions.

The company emphasizes that this research reflects scientific investigation into formulation science and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

Scaling Distribution in the U.S. Market

Carmed’s U.S. strategy focuses on expanding availability while maintaining alignment with regulatory standards and long-term scientific positioning.

“The upcoming Amazon launch represents an important step in increasing awareness and accessibility for Carmed’s formulations in the United States,” said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. “We are focused on building a strong foundation in the U.S. market through consistent product quality and a research-driven approach.”

The company expects to announce product availability and listing details on Amazon in the coming weeks.

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

Visit Carmed Pharmaceuticals website and visit them on Instagram.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Carmed Pharmaceuticals, a science-driven company specializing in standardized carvacrol-based formulations, announced plans to expand its U.S. presence with an upcoming launch on Amazon.

The expansion builds on Carmed’s entry into the United States market and represents the next step in making its research-driven botanical formulations more accessible to U.S. consumers through one of the world’s largest online retail platforms.

Carmed’s approach integrates traditional botanical knowledge with modern pharmaceutical methodology to develop standardized formulations designed to support immune resilience, cellular health, and overall physiological balance.

Expanding Access Through Amazon

The planned Amazon launch is designed to provide broader access to Carmed’s formulations while supporting the company’s long-term strategy of combining scientific development with scalable distribution.

By leveraging Amazon’s platform, Carmed aims to reach a wider audience seeking standardized, quality-controlled botanical formulations grounded in research and formulation science.

“Amazon allows us to make our formulations more accessible while maintaining our focus on scientific integrity and standardization,” said Mustafa Can, Founder of Carmed Pharmaceuticals. “Our goal is to ensure that every product reflects the same level of research, consistency, and quality that defines our development process.”

The company’s U.S. rollout is focused on accessibility, consistency, and maintaining alignment with regulatory standards as it expands into new distribution channels.

Product Portfolio Coming to Amazon

As part of its Amazon launch, Carmed Pharmaceuticals plans to introduce several of its flagship formulations:

• Vacrol® Kids Spray - A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4-11.

• S-Mix® - A synergy-driven formulation designed to support immune function and healthy cellular activity.

• Vacrol® Capsule - A standardized carvacrol formulation developed to support microbial balance and immune resilience.

• Vacrol-M® Capsule - A multi-component botanical formulation designed to support immune function and respiratory wellness.

• Omevaq-3® - A targeted formulation developed to support cellular energy metabolism and cognitive wellness.

Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.

According to the company, Carmed’s formulations are developed using standardized processes designed to ensure consistency, reproducibility, and quality control across product batches.

Scientific Foundation and Ongoing Research

Carmed’s development model is supported by ongoing research and collaboration with academic institutions, laboratories, and medical researchers focused on formulation science and bioactive compound evaluation.

In January 2026, a study published in the peer-reviewed journal Plants examined Vacrol® and S-Mix® in preclinical laboratory and in ovo models as part of broader scientific investigation into carvacrol-based formulations and multicomponent botanical interactions.

The company emphasizes that such research reflects scientific investigation into botanical bioactivity and formulation design and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

U.S. Market Expansion

Carmed states that its U.S. strategy is centered on building long-term credibility through scientific rigor, regulatory alignment, and consistent product quality as it expands distribution.

“The Amazon launch is an important step in making Carmed’s formulations available to a broader audience in the United States,” said Ceren Can, Global Brand Director of Carmed Pharmaceuticals. “We are focused on delivering consistent, high-quality products while continuing to build awareness around our research-driven approach to formulation development.”

The Amazon launch represents a key milestone in that strategy, enabling broader consumer access while supporting continued investment in research and formulation development.

Availability timelines and product listings on Amazon will be announced in the coming weeks.

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

Visit Carmed Pharmaceuticals website and visit them on Instagram.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Carmed Pharmaceuticals, a science-driven company specializing in standardized carvacrol-based formulations, is expanding into the United States market under the leadership of its founder, Mustafa Can.

The U.S. expansion follows years of research and formulation development led by Can, who established Carmed Pharmaceuticals in 2019 after several years of prior scientific exploration focused on standardized botanical bioactives and mechanism-based product design.

Carmed’s approach integrates traditional botanical knowledge with modern pharmaceutical methodology to create formulations designed to support immune resilience, cellular health, and overall physiological balance.

Founder Vision Behind Carmed Pharmaceuticals

Mustafa Can founded Carmed Pharmaceuticals with the goal of developing scientifically structured botanical formulations built on measurable mechanisms of action and rigorous quality control rather than trend-driven supplement concepts.

Before founding Carmed Pharmaceuticals, Mustafa Can built his career in the maritime industry as a ship master, navigating commercial vessels rather than laboratories. But about a decade ago, a personal fascination with longevity and preventive wellness set him on an unexpected new course. Without formal scientific training, Can immersed himself in an intense period of self-directed study—reviewing thousands of scientific publications and exploring the chemistry of botanical compounds used in traditional medicine. Over time, that curiosity evolved into a focused investigation of standardized, research-driven formulations centered on carvacrol and related bioactive ingredients.

As Carmed grew, that independent research effort expanded into a broader scientific initiative. Today, the company operates with a core team of approximately 25 full-time professionals and collaborates with a broader network of physicians, researchers, laboratories, and medical institutions involved in formulation development and scientific evaluation of bioactive compounds. What began as a personal pursuit of understanding ultimately became the foundation of Carmed Pharmaceuticals and its science-focused approach to botanical formulation development.

“From the beginning, our objective was to approach botanical formulations with scientific discipline,” said Can. “We wanted to focus on standardization, reproducibility, and analytical validation so that formulations are developed with a clear and consistent scientific rationale.”

Can added that Carmed’s long-term strategy prioritizes continued research and product development, with significant resources reinvested into scientific investigation and formulation development.

Today, Carmed operates with a research-driven framework that includes in vitro analysis, mechanism-based evaluation, formulation standardization, and structured quality control processes. All Carmed products are manufactured in facilities operating in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards.

Product Portfolio Entering the U.S.

As part of its U.S. expansion, Carmed Pharmaceuticals plans to introduce several of its flagship formulations:

• Vacrol® Kids Spray – A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4–11.

• S-Mix® – A synergy-driven formulation designed to support immune function and healthy cellular activity.

• Vacrol® Capsule – A standardized carvacrol formulation developed to support microbial balance and immune resilience.

• Vacrol-M® Capsule – A multi-component botanical formulation designed to support immune function and respiratory wellness.

• Omevaq-3® – A targeted formulation developed to support cellular energy metabolism and cognitive wellness.

Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.

According to Can, Carmed’s development strategy focuses on combining botanical bioactives in standardized formulations designed to interact across multiple biological pathways.

“Our formulations are built on what we describe as rational synergy,” Can said. “Rather than relying on isolated ingredients, we design standardized combinations selected to work together in a consistent and reproducible manner.”

Scientific Collaboration and Long-Term Positioning

Carmed’s research efforts are supported by collaborations with academic institutions, laboratories, and medical researchers involved in formulation science and bioactive compound evaluation. In January 2026, a study published in the peer-reviewed journal Plants examined Vacrol® and S-Mix® in preclinical laboratory and in ovo models as part of broader scientific investigation into carvacrol-based formulations and multicomponent botanical interactions.

The company emphasizes that such research reflects scientific investigation into botanical bioactivity and formulation design and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

As it enters the United States, Carmed states its strategy is focused on regulatory alignment, scientific credibility, and long-term positioning within the preventive wellness sector.

Distribution timelines and retail availability for the United States will be announced in the coming months.

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

Visit Carmed Pharmaceuticals website and visit them on Instagram.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.

Carmed Pharmaceuticals, a science-driven company specializing in standardized carvacrol-based formulations, has announced its expansion into the United States market.

The U.S. expansion is being formally announced in alignment with International Women’s Day on March 8, highlighting the company’s female leadership and its commitment to science-driven development within the preventive health sector.

Founded on a structured research pathway rather than short-term wellness trends, Carmed integrates traditional botanical knowledge with modern pharmaceutical technology to develop quality-controlled formulations designed to support immune resilience, cellular health, and overall physiological balance.

Officially established in 2019 following several years of focused research and development, the company brings nearly 15 years of industry experience to its U.S. expansion strategy.

Research-Driven Foundation

Carmed Pharmaceuticals was built around a strategic R&D model centered on formulation standardization, analytical validation, and reproducible development processes.

“Our foundation is not built on trends,” said Mustafa Can, Founder and CEO of Carmed Pharmaceuticals. “From the beginning, our objective has been to develop scientifically structured formulations guided by mechanism-based research and rigorous quality control. We combine nature’s bioactive potential with disciplined pharmaceutical methodology.”

All Carmed products are manufactured in facilities operating in accordance with Good Manufacturing Practice (GMP) principles and applicable regulatory standards, with an emphasis on safety, consistency, and long-term quality assurance.

Product Portfolio Entering the U.S.

Carmed Pharmaceuticals will introduce several of its flagship formulations to the U.S. market:

• Vacrol® Kids Spray – A carvacrol-based spray formulated to support upper respiratory wellness and microbial balance for children ages 4–11.

• S-Mix® – A synergy-driven formulation designed to support immune function and healthy cellular activity

• Omevaq-3® – A targeted formulation developed to support cellular energy metabolism and cognitive wellness.

Vacrol® Kids Spray and S-Mix® are gluten-free, non-GMO, sugar-free, preservative-free, and halal-certified.

“Our formulations are designed around rational synergy,” Can added. “Rather than relying on single ingredients, we develop standardized combinations selected to interact across multiple biological pathways in a consistent and reproducible manner.”

Scientific Collaboration and Long-Term Positioning

Carmed maintains academic collaborations and supports peer-reviewed research exploring bioactive mechanisms and formulation science. The company emphasizes that its research reflects scientific inquiry into botanical bioactivity and standardization practices and is not presented as evidence that its consumer products diagnose, treat, cure, or prevent any disease.

As it enters the United States, Carmed states its strategy is focused on regulatory alignment, long-term credibility, and preventive wellness positioning.

Distribution timelines and retail availability will be announced in the coming months.

About Carmed Pharmaceuticals

Carmed Pharmaceuticals is a research-driven company specializing in standardized, mechanism-based botanical formulations rooted in Anatolia’s rich botanical heritage. Integrating traditional plant knowledge with modern pharmaceutical technology, Carmed focuses on analytical validation, quality control, and reproducible formulation design.

Officially established in 2019 following years of focused research and development, the company operates with nearly 15 years of industry experience. All products are manufactured in accordance with Good Manufacturing Practice (GMP) principles and relevant regulatory standards, emphasizing safe production, environmental awareness, and continuous quality improvement.

Carmed develops standardized formulations designed to support preventive wellness, immune resilience, and cellular health through science-informed, quality-controlled processes.

Visit Carmed Pharmaceuticals website and visit them on Instagram.

This press release is distributed by the Newsworthy.ai™ Press Release Newswire - News Marketing Platform™. Reference URL for this press release is here.